Skip to content

Study to Evaluate the Effect of an Ayurveda Compound in Recurrent Respiratory Infections

Study to Evaluate the Immunomodulatory Effect of Swarna-Vacha Yog and its role in Pranavaha Srotodushti in Children W.S.R. to Recurrent Respiratory Infections in Children

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/03/024389
Enrollment
102
Registered
2020-03-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J989- Respiratory disorder, unspecified

Interventions

Intervention1: Swarna-Vacha Yoga: Herbomineral compound, 1drop/kg/day orally in two divided doses for 2 months duration Control Intervention1: Honey drops: Honey drops, 1drop/kg/day orally in two divi

Sponsors

National Institute of Ayurveda Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Children whose parents are willing to give consent for clinical trial. 2) Children aged between 01 to 05 years of either sex. 3) Children with recurrent respiratory infections.

Exclusion criteria

Exclusion criteria: 1) Children suffering from major systemic illness necessitating long term treatment. 2) Children with evidence of malignancy, genetic or congenital anomaly. 3) Children with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4) Co-morbidity like TB, UTI and bleeding disorders etc. 5) H/o hypersensitivity to any of the trial drug or their ingredients. 6) Children who have completed participation in any other clinical trial during the past six months.

Design outcomes

Primary

MeasureTime frame
Change in Ig GTimepoint: baseline and 56th day of starting of trial

Secondary

MeasureTime frame
Symptomatic reliefTimepoint: every 14th day after intervention of drug

Countries

India

Contacts

Public ContactRashmi Pareek

National Institute of Ayurveda

drnishaojha@gmail.com07891832811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026